Here, we demonstrated that minocycline significantly improved IFN-α-induced depression-like behaviors while concomitantly suppressing microglial activation and restoring hippocampal neurogenesis (Figure 3). The gene discussed is IFNA1; the disease is depressive symptom measurement.